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A small-molecule catalyst of protein folding in vitro and in vivo
Kenneth J Woycechowsky1, K Dane Wittrup2* and Ronald T Raines1,3
Background: The formation of native disulfide bonds between cysteine residues
often limits the rate and yield of protein folding. The enzyme protein disulfide
isomerase (PDI) catalyzes the interchange of disulfide bonds in substrate
proteins. The two -Cys–Gly–His–Cys- active sites of PDI provide a thiol that has
a low pKa value and a disulfide bond of high reduction potential (E°′). 
Results: A synthetic small-molecule dithiol, (±)-trans-1,2-bis(2-mercapto-
acetamido)cyclohexane (BMC), has a pKa value of 8.3 and an E°′ value of
–0.24 V. These values are similar to those of the PDI active sites. BMC
catalyzes the activation of scrambled ribonuclease A, an inactive enzyme with
non-native disulfide bonds, and doubles the yield of active enzyme. A monothiol
analog of BMC, N-methylmercaptoacetamide, is a less efficient catalyst than
BMC. BMC in the growth medium of Saccharomyces cerevisiae cells increases
by > threefold the heterologous secretion of Schizosaccharomyces pombe acid
phosphatase, which has eight disulfide bonds. This effect is similar to that from
the overproduction of PDI in the S. cerevisiae cells, indicating that BMC, like
PDI, can catalyze protein folding in vivo.
Conclusions: A small-molecule dithiol with a low thiol pKa value and high
disulfide E°′ value can mimic PDI by catalyzing the formation of native disulfide
bonds in proteins, both in vitro and in vivo.
Introduction
The formation of native disulfide bonds is the rate-deter-
mining step in the folding of many proteins. Reduced,
unfolded proteins containing multiple cysteine residues
tend to oxidize rapidly and nonspecifically. The non-
native disulfide bonds formed during oxidative folding
must then be isomerized to achieve the correct cysteine
pairings. The greater the number of cysteine residues in
an amino acid sequence, the more possibilities arise for
incorrect disulfide arrangements. Given that the native
structure is required for protein function and that disulfide
bonds are often crucial for structural stability, it is not sur-
prising that, in vivo, native disulfide bond formation is an
enzyme-catalyzed process [1].
Protein disulfide isomerase (PDI; EC 5.3.4.1) is essential
for the viability of Saccharomyces cerevisiae cells [2].
Although PDI has many known functions [3], its essential
role is to catalyze the unscrambling of non-native disulfide
bonds in other proteins [4]. PDI is a 57 kDa resident of
the endoplasmic reticulum (ER). Each PDI molecule has
two active sites that contain the sequence: -Cys–Gly–
His–Cys- [5]. Only the amino-terminal cysteine residue in
each active site is necessary for catalysis of disulfide bond
isomerization [4,6].
A simple chemical mechanism for catalysis by PDI begins
with the nucleophilic attack of its active-site thiolate on a
non-native disulfide bond (Figure 1) [7,8]. This attack
results in an intermolecular (i.e. mixed) disulfide and a sub-
strate thiolate. Further disulfide rearrangements are then
induced by this substrate thiolate. The attainment of the
native three-dimensional structure guides the formation of
native disulfide bonds and, ultimately, the release of PDI.
A striking feature of this mechanism is that it requires the
enzyme to provide only a reactive thiolate [7,8].
In a given pH and redox environment, the fraction of PDI
active sites that have a thiolate is governed by two factors
[9,10]. One is the value of the formal reduction potential
(E°′) of the disulfide bond that forms between the two cys-
teine residues in each active site. The other factor is the
value of the acid dissociation constant (Ka) of the nucle-
ophilic thiol. In PDI, the active-site disulfide bond has an
E°′ of –0.18 V, and the thiol of the amino-terminal active-
site cysteine residue has a pKa of 6.7 [11,12]. These two
physical parameters can be combined with the properties of
the ER (Esolution = –0.18 V and pH 7 [13]) to reveal that 33%
of the PDI active sites in the ER contain a thiolate [14].
The -Cys–Xaa–Xaa–Cys- (CXXC; where X is any amino
acid) active-site motif of PDI is also found in homologous
thiol : disulfide oxidoreductases. The best characterized
thiol : disulfide oxidoreductase is the Escherichia coli
thioredoxin (Trx), a 12 kDa cytosolic reducing agent for
ribonucleotide reductase and other proteins [15,16]. Trx
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has a -Cys–Gly–Pro–Cys- active site with an E°′ value of
–0.27 V [17] and pKa value of 7.5 [18]. Wild-type Trx
cannot replace PDI in S. cerevisiae cells because only
0.021% of Trx active sites would contain a thiolate in the
ER. Trx variants with higher fractions of thiolate can,
however, substitute for PDI in vivo [14]. This finding
demonstrates that a small homolog can mimic PDI. Here,
we take the next step.
We reasoned that the two active-site thiols of PDI are its
most important functional groups, and that a small-molecule
dithiol with appropriate E°′ and pKa values could likewise
be an effective catalyst of disulfide bond isomerization. The
dithiol (±)-trans-1,2-bis(mercaptoacetamido)cyclohexane
(BMC) had been studied previously as a technetium
ligand [19] and as a reducing agent [20]. Here, we synthe-
size BMC and show that it has E°′ and pKa values similar
to those of PDI. We find that BMC catalyzes disulfide
bond isomerization, both in vitro and in vivo, and is more
efficient than its monothiol analog, N-methylmercaptoac-
etamide (NMA).
Results
Synthesis and properties of BMC
We synthesized BMC from (±)-trans-1,2-diaminocyclo-
hexane using the three-step route outlined in Figure 2.
The overall yield was 23%, or 11 g BMC from 24 ml 
starting material.
The acid dissociation constant of a titratable group can be
determined by measuring the equilibrium concentrations
of its protonated and unprotonated forms over a pH range
broad enough to encompass the transition from largely
protonated to largely unprotonated. The absorbance at
238 nm (A238) of a thiolate exceeds that of its correspond-
ing protonated form. We measured the thiol pKa values of
BMC and NMA using this UV signature. Our analysis of
A238 as a function of pH indicates that the mercaptoacet-
amido groups of BMC have thiol pKa1 = 8.3 and pKa2 = 9.9
(Figure 3a). The pKa1 for BMC is in good agreement with
that obtained for NMA, which has pKa = 8.3 (Figure 3b).
As a control, a pH titration of glutathione was also per-
formed, giving a thiol pKa of 9.0 (data not shown).
The reduction potential of a redox-active group can be
determined by measuring the equilibrium concentrations
of its oxidized and reduced forms in the presence of the
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Figure 1
Putative chemical mechanism for catalysis of
disulfide bond isomerization by protein
disulfide isomerase [7,8]. The enzymic active
site has two thiols, which enables the enzyme
to escape from nonproductive mixed
disulfides. After escape, additional redox
reactions can lead ultimately to native protein
and reduced catalyst.
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Figure 2
Synthetic route to (±)-trans-1,2-bis(mercaptoacetamido)cyclohexane
(BMC).
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oxidized and reduced forms of a reference molecule of
known reduction potential. To determine the reduction
potential of BMC, we developed a high-performance
liquid chromatography (HPLC) method using β-mercapto-
ethanol (βME; E°′βME = –0.260 V [21]) as a reference. As
measured by HPLC analysis of the thiol–disulfide
exchange equilibrium between BMC and βME, the E°′ of
BMC is 0.241 ± 0.002 V. This value is the mean (± SD) of
five independent assays starting with different concentra-
tions of BMC and βME.
Having characterized its relevant chemical properties
(Table 1), we subjected BMC to two distinct assays for
biological catalysis, one in vitro and one in vivo.
Activity in vitro
Bovine pancreatic ribonuclease A (RNase A; EC 3.1.27.5)
has eight cysteine residues, which in the native enzyme
form four disulfide bonds. The ability of BMC to catalyze
in vitro disulfide bond isomerization was assessed by mon-
itoring the activation of scrambled RNase A (sRNase A),
which is fully oxidized RNase A with a random distribu-
tion of disulfide bonds. sRNase A is a poor catalyst of
RNA cleavage, as few of the enzyme molecules are folded
properly. An increase in the rate of RNA cleavage is
indicative of an increase in the concentration of RNase A
molecules with native disulfide bonds.
The presence of BMC increased the rate of activation of
sRNase A (Figure 4). Perhaps more significantly, the pres-
ence of BMC enhanced by twofold the final yield of
native RNase A. NMA also showed unscrambling activity
in the in vitro assay (Figure 4). Unlike BMC, NMA was
not able to activate sRNase A completely. Still, the final
concentration of native RNase A produced by NMA was
greater than that produced by the glutathione redox buffer
alone. Apparently, a small-molecule dithiol is more effi-
cient at unscrambling than is a small-molecule monothiol.
Assays with other concentrations of BMC and NMA (or
with the glutathione redox buffer alone) gave results
similar to those in Figure 4 (data not shown).
Activity in vivo
Many of the proteins secreted from eukaryotic cells have
multiple disulfide bonds. Those proteins that do not fold
quickly and properly are degraded rather than secreted
[22,23]. Increasing the endogenous levels of PDI can
increase the efficiency of secretion for some of these pro-
teins [24,25]. Presumably, a molecule of small mass and
little charge, such as BMC, could gain access to the ER of
a yeast cell, where these secretory proteins fold. An
increase in heterologous secretion would be consistent
with BMC having disulfide isomerization activity inside
the cell, because only properly folded proteins are
secreted by eukaryotes [26].
Research Paper  Small-molecule catalyst of protein folding Woycechowsky, Wittrup and Raines    873
Figure 3
Effect of pH on the absorbance at 238 nm (A238) of (a) BMC
(0.10 mM) and (b) NMA (0.14 mM) in 0.10 M potassium phosphate
buffer. Fitting the BMC data to equation 2 (r2 > 0.99) and the NMA
data to equation 1 (r2 > 0.99) gives pKa1 = 8.3 and pKa2 = 9.9 for
BMC and pKa = 8.3 for NMA.
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Table 1
Properties of (±)-trans-1,2-bis(mercaptoacetamido)cyclohexane.
Molecular mass (Da) 262
E°′ (V) –0.24
pKa 8.3; 9.9
Fraction thiolate* 0.16
Specific activity (U/mg)† 0.4
*Fraction thiolate was calculated using the procedure outlined in [8] for
a pH 7.6 solution containing 1.0 mM BMC, 1.0 mM reduced
glutathione (GSH) and 0.2 mM oxidized glutathione (GSSG) like that
used in the in vitro assays. †One unit (U) catalyzes the activation of
1 pmol of sRNase A per minute in Tris–HCl buffer (pH 7.6) containing
GSH (1.0 mM) and GSSG (0.2 mM).
Native Schizosaccharomyces pombe acid phosphatase is a
30 kDa homodimer with eight disulfide bonds (six intra-
chain and two interchain) and many possibilities for incor-
rect pairings. Not surprisingly, increased expression of
endogenous PDI increases the yield of secreted enzyme
[24,27]. The addition of BMC to the growth medium of
S. cerevisiae cells producing basal levels of PDI increased
the yield of secreted S. pombe acid phosphatase (Figure 5).
The presence of 0.1 mg/ml BMC in the growth medium
increases phosphatase secretion by over threefold, equiva-
lent to the increase achieved with 15-fold overproduction
of PDI [24]. Higher concentrations of BMC do not lead to
higher levels of phosphatase. This accordance of achiev-
able yield suggests that a step other than catalysis of disul-
fide bond isomerization limits heterologous secretion from
S. cerevisiae cells treated with BMC or excess PDI. Addi-
tion of BMC to cells overproducing PDI produces no
incremental increase in phosphatase secretion (data not
shown), consistent with a shared mechanism of action
between BMC addition and PDI overproduction.
Discussion
Disulfide bond interchange is a facile chemical reaction
[28]. The high nucleophilicity of thiolates and high elec-
trophilicity of disulfide bonds allow for rapid thiol–disul-
fide interchange. Nevertheless, enzymes have evolved to
catalyze this reaction [1]. The enzyme PDI catalyzes the
isomerization of non-native disulfide bonds in substrate
proteins. The chemical basis for catalysis by PDI results
from thiol pKa and disulfide E°′ values that produce a high
fraction thiolate in PDI’s native environment — the ER of
eukaryotic cells [14,10]. If a high fraction thiolate is the
sole requirement for catalysis of disulfide bond isomeriza-
tion, then it should be possible to design and synthesize
an effective small-molecule catalyst of protein folding.
In 1962, Haber and Anfinsen [29] demonstrated that low
concentrations of βME could activate sRNase A. Gluta-
thione redox buffers have been used extensively to study in
vitro oxidative protein folding [30–34]. The use of monoth-
iols to refold proteins is complicated by the observation that
the rates and yields of folding reactions do not parallel the
redox potential of the solution [33]. The glutathione redox
buffer composition for optimum folding of reduced RNase
A has been determined empirically by systematic variation
of both the ratio of reduced glutathione (GSH) to oxidized
glutathione (GSSG) and the total concentration of the two
components. At higher total glutathione concentrations,
mixed disulfide intermediates accumulate and become
trapped. Dithiols have an advantage over monothiols (such
as glutathione) in that mixed disulfide intermediates can be
cleaved by intramolecular disulfide bond formation.
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Figure 4
Time course for the activation of scrambled ribonuclease A by various
thiols. All unscrambling reactions were performed at 30°C in 50 mM
Tris-HCl buffer (pH 7.6) containing glutathione alone (1.0 mM GSH;
0.2 mM GSSG; black triangles) or glutathione (1.0 mM GSH; 0.2 mM
GSSG) plus BMC (red circles; 1.0 mM = 0.26 mg/ml) or NMA (blue
squares; 2.0 mM). Data points are the average of triplicate
measurements, and are fitted to equation 4. 
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Figure 5
Dependence of Schizosaccharomyces pombe acid phosphatase
secreted from S. cerevisiae on BMC concentration. Cells were grown
for 48 h before the assay. In the absence of BMC, A435/OD600 = 0.014
(see [24]). Data points are the average of ten replicate measurements.
The dotted line represents phosphatase secretion from an isogenic
strain in which yeast PDI is overproduced by 15-fold from a single
integrated gene [24].
0 0.1 0.2 0.3 0.4
N
at
iv
e 
ph
os
ph
at
as
e 
pe
r c
el
l (
re
la
tiv
e)
Concentration of BMC (mg/ml)
15-fold PDI
overproducer
1
2
3
4
Chemistry & Biology
Previous attempts at using small dithiols to refold proteins
have met with only moderate success. Short peptides con-
taining a PDI-like -Cys–Gly–His–Cys- sequence have
modest PDI-like activity [35]. The low activity of these
peptides relative to PDI probably stems from the loss of
the protein context. Specifically, the nucleophilic thiol in
the active sites of known thiol :disulfide oxidoreductases
is positioned at the amino terminus of an α helix, which
provides a depressed thiol pKa because of the thiol inter-
acting with the helix dipole [36]. Moreover, the CXXC
sequence is constrained structurally to provide an active-
site disulfide bond of appropriate E°′. 
Dithiothreitol (DTT) is a poor oxidant of dithiols
(E°′ = –0.327 V [21]). Yet, native RNase A has been pro-
duced from the reduced enzyme by using only oxidized
DTT [37]. The concentration of DTT used in this experi-
ment was high (0.1 M), and still the refolding rate was
slower than that with much lower concentrations of oxi-
dized glutathione. The purpose of using DTT as an
oxidant was, however, to demonstrate that a dithiol can
oxidize reduced RNase A without the accumulation of
mixed disulfide intermediates. Further experiments
showed that although DTT oxidizes RNase A more than
100-fold more slowly than does glutathione, DTT is able
to rearrange disulfide-containing folding intermediates
slightly more quickly than is glutathione [38,39]. It is diffi-
cult to create conditions that would favor the isomeriza-
tion, rather than the reduction, of disulfide bonds by
DTT. The stability of its disulfide bond and its high thiol
pKa of 9.2 [20] combine to give an exceedingly low frac-
tion of DTT molecules in the thiolate form. At pH = 7
and Esolution = –0.18 V, fewer than one in a million DTT
molecules would contain a thiolate, severely limiting its
efficacy as a catalyst of disulfide bond isomerization.
Thiol pKa of reduced BMC
Reduced BMC has a low (first) pKa value. Inductive effects
from the electronegative oxygen and nitrogen lower the
thiol pKa from 10.6 (which is the pKa of propyl mercaptan
[40]) to 8.3 (Figure 2a). This pKa value differs from that
reported previously for mercaptoacetamido groups. Using a
similar method, other workers [20] reported pKa values of
7.6–7.8 for the thiols of this group. Their values were deter-
mined by fitting the pH-titration data to an equation differ-
ent from ours and derived after making the assumptions
that the extinction coefficient of the fully protonated form
is zero and that the extinction coefficient of the doubly
unprotonated form is twice that of the singly unprotonated
form. Indeed, when using the equation from [20] to fit our
pH-titration data, the pKa value is 7.7. This fit is, however,
much worse than that using our equation (Figure 3a). For
NMA, a thiol pKa of 8.05 was determined previously by
electrometric titration [41]. The (macroscopic) thiol pKa
value measured here for glutathione is 9.0, which is in the
range of those previously reported (8.6–9.2) [41–45], and
precisely between the two microscopic thiol pKa values of
8.93 and 9.08 determined in a careful study using 1H
nuclear magnetic resonance (NMR) spectroscopy [43].
Disulfide reduction potential of oxidized BMC
The disulfide bond of oxidized BMC has a reduction
potential of –0.24 V. This value differs from that reported
previously. From 1H NMR spectra of solutions containing
DTT and BMC, Lamoureux and Whitesides [20] reported
that the E°′ of BMC was ≥ –0.21 V. This method is impre-
cise because the reduction potential of BMC is much
greater than that of DTT. In a redox equilibrium between
equal amounts of BMC (E°′ = –0.24 V) and DTT
(E°′ = –0.327 V [21]), only 0.1% of the BMC molecules
will be in the oxidized form.
Two factors are responsible for this value being higher than
that of, say, DTT. The major contributor to the increase is
that a ten-membered ring has conformational strain, which
is relieved in the reduced molecule. A minor factor arises
from the inductive effect — disulfide bonds are more easily
reduced if they are formed from thiols with lower pKa
values [10]. As calculated from equation 5 of [10], having
mercaptoacetamido groups rather than two propyl mercap-
tan groups increases the E°′ value of BMC by 0.0007 V.
Catalysis in vitro
The relevant chemical and catalytic parameters of BMC
are listed in Table 1. These parameters highlight the
value of the mercaptoacetamido group, which has much
merit for small-molecule catalysts of protein folding. In
particular, the mercaptoacetamido group will be 100-fold
more ionized at pH 7 than a simple alkyl thiol. Moreover,
virtually any primary or secondary amine can be elabo-
rated into a mercaptoacetamido group by a synthetic route
analogous to that in Figure 2.
Although BMC is an effective catalyst of disulfide bond
isomerization, its specific activity is approximately 500-
fold less than that of PDI (data not shown). PDI has three
attributes that could be responsible for its greater efficacy
as a catalyst. First, PDI has a lower thiol pKa value, a
higher disulfide E°′ value, and hence a higher fraction of
thiolate. Under any solution conditions, the fraction of
PDI molecules in the thiolate form would always exceed
that for BMC. Second, PDI has a peptide-binding site
that enables the formation of a noncovalent complex with
a substrate [46,47]. The use of binding energy probably
lowers the free energy of the chemical transition state
[48,49]. In contrast, BMC collides indiscriminately with
other molecules. Third, PDI could interact preferentially
with proteins and so could discriminate against gluta-
thione. For example, the glutamate and cysteine residues
of glutathione are linked by an irregular (and thus easily
distinguishable) amide bond to the γ-carboxyl group of
the glutamate residue. BMC cannot discriminate against
Research Paper  Small-molecule catalyst of protein folding Woycechowsky, Wittrup and Raines    875
glutathione and may be compromised by the formation of
mixed disulfides with the redox buffer. 
NMA, a small molecule monothiol, is a less efficient cata-
lyst of disulfide bond isomerization than is BMC. A com-
parison of these two catalysts provides insight into the role
of the second thiol group. In the presence of 2.0 mM
NMA (which provides the same concentration of thiol as
1.0 mM BMC), full activation of substrate is not achieved
(Figure 4). This result is interpretable in terms of the
mechanism shown in Figure 1. The product of the first
step of this mechanism is a covalent catalyst–substrate
complex. Further productive steps in this mechanism rely
on the ability of the substrate thiolate to induce further
rearrangements. If a disulfide bond isomerization is hin-
dered, the substrate will be slow to rearrange. A monothiol
catalyst would then be trapped. In contrast, a dithiol cata-
lyst could escape from the trapped complex via the forma-
tion of an intramolecular disulfide bond within the
catalyst. This disulfide can then be converted back into a
dithiol by reaction with the redox buffer or reduced sub-
strate, enabling another attempt at catalysis. In effect, this
second thiol group acts like a clock, providing a set
amount of time for the substrate to rearrange and free the
catalyst before an intramolecular attack within the catalyst
disrupts the complex [6,50]. The difference between the
concentration of substrate ultimately activated by a dithiol
(BMC) and that activated by a monothiol (NMA or the
glutathione redox buffer alone) probably reflects the pro-
duction of such trapped complexes.
The greater activation rate and increased yield of active
RNase A observed for NMA over glutathione alone
(Figure 4) may result from the decreased pKa of the thiol
in NMA (pKa = 8.3) relative to that in glutathione
(pKa = 9.0). This pKa difference results in an increased
fraction of thiolate in NMA, which increases the popula-
tion of catalytically active species and thus the activation
rate. In addition, the lower pKa of NMA makes it a better
leaving group from mixed disulfides, making it easier for
NMA to escape from trapped complexes and thereby
increasing the yield of folded protein.
Catalysis in vivo
DTT can enter the ER of mammalian cells and prevent
the formation of disulfide bonds there [51]. For BMC to
exhibit PDI-like activity in vivo, it too must enter the ER.
The heterologous secretion data suggest that BMC does
do so (Figure 5). We suspect that the cell permeability of
BMC is enhanced by its lipophilic cyclohexyl ring.
Misfolded proteins with non-native disulfide bonds do
occur in vivo and are costly to a cell. Co-overproduction of
PDI has been a successful strategy for increasing the output
efficiency of some overproduced secretory proteins [24].
The in vivo activity of BMC suggests that a similar increase
can be obtained simply by adding BMC to the growth
medium. Indeed, BMC is the first small-molecule thiol
shown to increase the secretion of a heterologous protein.
The pinnacle of biochemical understanding is de novo
design. To design a minimized mimic of a protein requires
a detailed understanding of its function, as a minimal mol-
ecule would contain only those chemical groups that are
required for function [52]. Some notable success has been
attained in creating small mimics of proteins and peptides
[53]. For example, a dimer of 20-residue peptides can sub-
stitute for erythropoiten, which is a 34 kDa glycoprotein
[54,55]. The 28-residue atrial natriuretic peptide has been
shrunk to 15 residues with only a moderate loss in activity
[56]. A few enzymes have been minimized effectively
[57]. A 14-residue peptide can catalyze the decarboxyla-
tion of oxaloacetate in place of acetoacetate decarboxylase
[58]. Organoselenium compounds can imitate the active-
site selenocysteine residue of glutathione peroxidase [59].
To the best of our knowledge, however, BMC is the first
small-molecule mimic of an enzyme that has been shown
to function both in vitro and in vivo.
Prospectus
An effective, small-molecule mimic of PDI could have
numerous practical applications. BMC is useful for in vitro
protein folding on a preparative scale. Often, overproduc-
tion of proteins in E. coli leads to the formation of inclusion
bodies [60]. These insoluble aggregates must be solubi-
lized by reduction and denaturation, and then refolded by
dilution into an appropriate redox buffer. The most com-
monly used redox buffer contains reduced and oxidized
glutathione, as used here. As a monothiol, glutathione lacks
the ability to escape from nonproductive complexes with
protein, and can lead to low yields of properly folded
protein (Figure 4). Also, the high thiol pKa of glutathione
(9.0) leads to slow disulfide bond isomerization at pH 7.
The use of PDI itself for preparative-scale protein folding
is hindered by the high cost and instability of enzymic cata-
lysts and by the problem of separating PDI from the target
protein. In contrast, a small-molecule catalyst is inexpen-
sive, inert, and readily separable from a target protein by
filtration, dialysis or size-exclusion chromatography.
Some proteins cannot be refolded efficiently in vitro and
are best produced in their native state. Creating a new
strain of a microorganism that overproduces PDI (or other
enzymic catalyst) can improve the isolated yield of a
secreted protein [24], but is tedious to effect. Small mol-
ecules such as BMC may obviate the need for such manip-
ulations by achieving a similar effect through addition to
the growth medium (Figure 5).
In addition to improving the production of heterologous
proteins, small-molecule catalysts of protein folding could
have other utility. Several important diseases have been
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implicated as arising from defects in protein folding
[61–63]. Bioavailable molecules such as BMC could serve
as the basis for therapies for such diseases. For example, a
small-molecule catalyst of protein folding could act directly
by catalyzing the proper folding of the aberrant protein
responsible for the etiology of the disease. Alternatively,
the catalyst could act indirectly by making the protein-
folding machinery of the diseased cells more efficient
overall, thereby allowing endogenous processes to fold a
higher fraction of the aberrant protein. Finally, a synthetic
folding catalyst could ameliorate the symptoms (rather
than the cause) of a disease by catalyzing the folding of
proteins whose folding is adversely affected by the disease.
It is noteworthy that BMC is likely to be well tolerated by
human cells because its E°′ value is not extreme, but is
between the Esolution of the ER and cytosol [13].
Significance
A synthetic small-molecule dithiol, (±)-trans-1,2-bis(2-
mercaptoacetamido)cyclohexane (BMC), has thiol pKa
and disulfide reduction potential (E°′) values similar to
those of the essential enzyme protein disulfide isomerase
(PDI). Like PDI, BMC catalyzes the unscrambling of
non-native protein disulfide bonds in vitro and enhances
the yield of a protein-folding reaction. Addition of BMC
to Saccharomyces cerevisiae growth medium increases
the heterologous production of a protein with multiple
disulfide bonds. BMC is therefore the first small-mol-
ecule thiol shown to increase the secretion of a protein.
NMA, a monothiol analog of BMC, is a less efficient cat-
alyst than BMC. This observation supports an unscram-
bling mechanism in which the second thiol of BMC
allows escape from nonproductive mixed disulfides. The
desirable attributes of PDI can therefore be mimicked in
a small-molecule catalyst of significant practical utility.
Materials and methods
General
(±)-trans-1,2-Diaminocyclohexane, chloroacetyl chloride, βME and
2-hydroxyethyldisulfide (βMEox) were from Aldrich Chemical (Milwau-
kee, WI). Thioacetic acid was from Acros Organics (Pittsburgh, PA).
NMA was from Fluka (Buchs, Switzerland). sRNase A, GSH and
GSSG were from Sigma Chemical (St. Louis, MO). Poly(C) was from
Midland Certified Reagents (Midland, TX) and was precipitated from
aqueous ethanol (70% v/v) before use. Yeast nitrogen base was from
Difco (Detroit, MI). All other chemicals were of reagent grade or better,
and were used without further purification.
Thiol concentrations were determined using the method of Ellman [64].
Ultraviolet absorbance measurements were made on a Cary Model 3
spectrophotometer equipped with a Cary temperature controller, from
Varian (Sugar Land, TX).
Synthesis of BMC
(±)-trans-1,2-Bis(mercaptoacetamido)cyclohexane (BMC) was synthe-
sized by a route similar to those described previously [19,20]. This
route is outlined in Figure 2.
(±)-trans-1,2-Diaminocyclohexane (22 g, 0.20 mol) and K2CO3 (56 g,
0.40 mol) were dissolved in 1 l ice-cold distilled water. Chloroacetyl
chloride (34 ml, 0.42 mol) was added dropwise and with stirring to this
solution. The resulting cloudy white mixture was stirred at 0°C for 1 h.
The precipitate was collected by filtration, washed with cold distilled
water, and dried under reduced pressure. The bis(choroacetyl) product
(17.5 g, 33%) was obtained as a white powder, which was judged to
be pure by 1H NMR analysis [20].
The bis(chloroacetyl) product (5.6 g, 21 mmol) was dissolved in 1 l of
methylene chloride, and this solution cooled to 0°C. Thioacetic acid
(6 ml, 83 mmol) was added dropwise and with stirring to the cooled
solution. Then, triethylamine (12 ml, 83 mmol) was added dropwise and
with stirring. The resulting solution was allowed to warm slowly to room
temperature and stirred under N2(g) for 40 h. The reaction was
quenched by the addition of 0.5 l of 0.35 M sodium acetate buffer
(pH 4). The layers were separated, and the organic layer washed with
an ice-cold solution of saturated aqueous sodium bicarbonate. The
organic layer was dried, filtered, and concentrated to yield a white
powder. This powder was purified by recrystallization from ethyl
acetate. The bis(thioacetate) product (6.2 g, 86%) was obtained as a
white powder, which was judged to be pure by 1H NMR analysis [20].
The bis(thioacetate) product (3.0 g, 8.75 mmol) was dissolved in
125 ml of 1.2 M HCl in methanol. The resulting clear solution was incu-
bated at room temperature under N2(g) for 20 h. The excess acid was
then removed by bubbling nitrogen gas through the solution, and the
solvent was removed under reduced pressure to yield a yellow oil. The
oil was dissolved in a minimal amount of methanol, and the resulting
solution was cooled in a dry ice/acetone bath. The supernatant was
decanted, and the white precipitate was dried under reduced pressure
to yield BMC (1.8 g, 80%) as a white solid, which was judged to be
pure by spectroscopic analysis: mp 193–194°C; IR (thin film) 3272,
3083, 2917, 2852, 2547, 1650, 1554, 1419, 1328, 1241, 1162,
974, 742, 700 cm–1; 1H NMR (CD3OD, 500 MHz) d 3.66 (br, s, 2 H,
NCH), 3.15 and 3.14 (2d, J = 14.5 Hz, 4 H, COCH2S), 1.94 (m, 2 H,
NCHCH2 eq.), 1.80 (m, 2 H, NCHCH2 ax.), 1.37 (m, 4 H,
NCHCH2CH2); MS (EI) calc’d for C10H18N2O2S2 m/e 262, found 262.
Synthesis of BMC-disulfide (BMCox)
The disulfide form of BMC was synthesized from BMC by oxidation
with I2. Briefly, BMC (0.05 g, 0.19 mmol) was dissolved in 0.19 l of
ethyl acetate at 0°C. KHCO3 (25 ml of a 10% w/v solution in water)
was added. A concentrated solution of I2 (0.088 g in 6 ml ethyl
acetate) was added dropwise and with stirring. I2 addition was stopped
when the BMC solution turned brown, and the solution was then
stirred on ice for 1 h. The reaction was quenched by the dropwise addi-
tion of aqueous sodium thiosulfate until the solution became colorless.
The organic layer was separated, dried with Na2SO4, filtered, and con-
centrated to yield a white powder. This powder was purified by recrys-
tallization from ethyl acetate. The BMCox product (56%) was judged to
be pure by spectroscopic analysis: mp 247°C; IR (thin film) 3246,
3066, 2937, 2845, 1633, 1558, 1400, 1326, 1151, 974, 746 cm–1;
1H NMR (d6-DMSO, 500 MHz) δ 8.0 (NH), 3.8 (NCH), 3.1 (COCH2S),
1.7 (NCHCH2), 1.3 (NCHCH2CH2); MS (EI) calc’d for C10H16N2O2S2
m/e 260, found 260.
Determination of thiol pKa
Thiol titration curves were obtained by measuring A238 as a function of
pH. Buffer stock solutions of KH2PO4, K2HPO4 and K3PO4 (0.10 M
each) were degassed and flushed with Ar(g). A stock solution of thiol
(1.5 mM BMC or 2.1 mM NMA) was prepared using KH2PO4. Different
ratios of the buffer stock solutions were combined in duplicate to give
two identical sets of 1 ml solutions. These sets of solutions varied in pH
according to the ratio of each buffer stock solution added. To each
duplicate pair of solutions, 70 µl of KH2PO4 was added to one and
used to set the A238 at zero. Next, 70 µl of thiol solution was added to
the corresponding sample, the A238 measured immediately, and the
solution recovered. After measuring the A238, the pH of each solution
was measured using a Beckman (Fullerton, CA) pH meter freshly cali-
brated with pH 4.00 and pH 10.00 standard solutions from Fisher
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(Pittsburgh, PA). This process was repeated for each pair of solutions
to generate a plot of A238 vs pH.
To determine pKa values, the A238 versus pH data were fitted to either
a single (for NMA) or a double (for BMC) titration model (equations 1
and 2, respectively):
(1)
(2)
derived from Beer's Law and the definition of the acid dissociation con-
stant. CT is the total thiol concentration, εSH and εSHSH are the extinction
coefficients of the fully protonated forms, εS– and εS–SH are the extinction
coefficients of the singly unprotonated forms, and εS–
S– is the extinction
coefficient of the doubly unprotonated form. Both the extinction coeffi-
cients and pKas were obtained as parameters of the curve fit.
Determination of disulfide reduction potential
Thiol-disulfide interchange equilibria were established between BMC
and βME. In a typical reaction, 25 ml flask containing solid BMC (1 mg)
was sealed with a septum and flushed with Ar(g) for 10 min. Potassium
phosphate buffer (pH 7.0; 10 ml of a 10 mM solution), that had been
saturated with Ar(g) was added, and the resulting mixture was stirred
for 10 min to dissolve the solid. Then, βMEox (0.1 ml of a 40 mM stock
solution in 10 mM potassium phosphate buffer, pH 7.0) was added,
and the ensuing thiol-disulfide interchange reaction was allowed to
reach equilibrium at 25°C for 24 h. Similar equilibria were established
with different starting concentrations of BMC and βMEox.
The equilibrated mixture was quenched with HCl (1:100 dilution of a
3 M solution) to prevent further reaction. An aliquot (0.1 ml) of the
quenched mixture was analyzed immediately by HPLC using a Waters
system equipped with a Spectra-Physics integrator and a Vydac analy-
tical C18 reverse phase column. The loaded column was eluted at
1.0 ml/min with water (5.0 ml) followed by a linear gradient
(20 ml + 20 ml) of acetonitrile (0–40% v/v). Compounds were
detected by their absorption at 205 nm. Four peaks were evident in the
chromatograms, and were anticipated to arise from BMC, BMCox, βME,
and βMEox. HPLC analysis of standard solutions revealed that the four
peaks did indeed correspond to βME (retention time: 7 min), βMEox
(19 min), BMCox (26 min), and BMC (28 min). No evidence for mixed
disulfides was apparent. To correlate peak area with concentration, cal-
ibration curves were developed for these compounds and were linear
over the concentration range used (data not shown). From these cali-
bration curves, the equilibrium concentration of each component was
determined, allowing calculation of E°′BMC, from the Nernst equation,
here: 
(3)
Assay for isomerase activity in vitro
The activation of sRNase A was monitored essentially as described
previously [65]. Refolding reactions were performed at 30°C in 50 mM
Tris-HCl buffer (pH 7.6) containing GSH (1.0 mM), GSSG (0.2 mM),
and catalyst (either 1.0 mM BMC or 2.0 mM NMA). BMC was delivered
from a 100-fold concentrated stock solution in methanol. Reactions (in
triplicate) were initiated by the addition of sRNase A (1.0 µl of a
0.5 mg/ml stock) to a final volume of 0.10 ml. At timed intervals,
aliquots were assayed for poly(C) cleavage activity as described until
no further increase in activity was observed. Data were fitted to the
equation:
[active RNase A] = [sRNase A]t = 0(1–e–[catalyst]kt) (4)
to obtain the value of the second-order rate constant, k. The difference
in k values for catalyzed and uncatalyzed reactions was used to calcu-
late the specific activity of the catalyst.
Assay for heterologous secretion
S. cerevisiae cells were engineered to overproduce S. pombe
acid phosphatase. S. cerevisiae strain BJ5464 (α ura3-52 trp1
leu2∆1 his3∆200 pep4::HIS3 prb1∆1.6R can1 GAL) was obtained
from the Yeast Genetic Stock Center (Berkeley, CA). BJ5464 was
transformed with a multicopy plasmid directing overproduction of S.
pombe acid phosphatase, as described previously [24]. Yeast cultures
(ten replicates) were grown in liquid medium of 50 mM HEPES buffer
(pH 6.5) containing BMC (0, 0.1, 0.2, or 0.4 mg/ml from a stock solution
in dimethyl sulfoxide), glucose (2% w/v), yeast nitrogen base (0.67%
w/v), and synthetic amino acid supplement [arginine (190 mg/l), methio-
nine (108 mg/l), tyrosine (52 mg/l), isoleucine (290 mg/l), lysine
(440 mg/l), phenylalanine (200 mg/l), glutamic acid (1260 mg/l), aspar-
tic acid (400 mg/l), valine (380 mg/l), threonine (220 mg/l), glycine
(130 mg/l), and the nucleotide adenine (40 mg/l)]. After 48 h of growth
at 30°C, the cells were harvested and the concentration of secreted
active S. pombe acid phosphatase in the supernatant was determined
by a colorimetric assay as described previously [24].
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